{"id":"chorionic-gonadotrophin","rwe":[{"pmid":"41887127","year":"2026","title":"Activity-based costing in the management of pregnancy of unknown Location: Comparing current practice in Denmark with the M6NP model, and the NICE guidelines.","finding":"","journal":"European journal of obstetrics, gynecology, and reproductive biology","studyType":"Clinical Study"},{"pmid":"41866201","year":"2026","title":"[Risk assessment of subsequent drug resistance in patients with chemoresistant gestational trophoblastic neoplasia].","finding":"","journal":"Zhonghua fu chan ke za zhi","studyType":"Clinical Study"},{"pmid":"41826105","year":"2025","title":"AI-driven paradigm shift in follicle ultrasound monitoring: from automated segmentation to clinical decision support.","finding":"","journal":"Reproductive biomedicine online","studyType":"Clinical Study"},{"pmid":"41720851","year":"2026","title":"LK-1: an investigational therapy targeting hCG-β in metastatic breast, bladder, ovarian, and cervical cancers.","finding":"","journal":"Scientific reports","studyType":"Clinical Study"},{"pmid":"41637911","year":"2026","title":"Risk of progesterone elevation in patients with low ovarian reserve using long-acting FSH IVF protocol: a randomized controlled trial.","finding":"","journal":"Reproductive biomedicine online","studyType":"Clinical Study"}],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"G03GA01","category":"atc"},{"label":"Active","category":"status"},{"label":"Controlled ovarian stimulation","category":"indication"},{"label":"Hypogonadotropic hypogonadism","category":"indication"},{"label":"Induction of final follicular maturation and luteinization","category":"indication"},{"label":"Induction of ovulation and pregnancy","category":"indication"},{"label":"Prepubertal cryptorchidism","category":"indication"},{"label":"Ferring","category":"company"},{"label":"Reproductive Control Agents","category":"pharmacology"}],"phase":"marketed","safety":{"safetySignals":[{"llr":529.727,"date":"","count":73,"signal":"Ovarian hyperstimulation syndrome","source":"DrugCentral FAERS","actionTaken":"Reported 73 times (LLR=530)"},{"llr":80.701,"date":"","count":11,"signal":"Adnexal torsion","source":"DrugCentral FAERS","actionTaken":"Reported 11 times (LLR=81)"}],"commonSideEffects":[],"contraindications":["Androgendependent neoplasm","Carcinoma of prostate","Precocious puberty"]},"trials":[],"aliases":[],"company":"Ferring","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=chorionic gonadotrophin","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T03:28:21.216025+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T03:28:26.841881+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=chorionic gonadotrophin","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T03:28:27.501223+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Luteinizing hormone/Choriogonadotropin receptor agonist","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T03:28:28.553491+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201509/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T03:28:28.215731+00:00"}},"allNames":"choriogonadotropin","offLabel":[],"synonyms":["chorionic gonadotropin","chorionic gonadotrophin","gonadotropin, chorionic","choriogonadotropin","human chorionic gonadotropin","serum gonadotropin"],"timeline":[],"aiSummary":"Choriogonadotropin is a protein that acts as an agonist to the Luteinizing hormone/Choriogonadotropin receptor. It is used in medical treatments for conditions such as preterm labor, infertility, and polycystic ovary syndrome, often in conjunction with other interventions like in vitro fertilization and intracytoplasmic sperm injection.","approvals":[{"date":"","orphan":false,"company":"FERRING","regulator":"FDA"}],"brandName":"Choriogonadotropin","ecosystem":[{"indication":"Controlled ovarian stimulation","otherDrugs":[{"name":"clomifene","slug":"clomifene","company":"Sanofi Aventis Us"},{"name":"drospirenone","slug":"drospirenone","company":"Exeltis Usa Inc"},{"name":"estradiol","slug":"estradiol","company":"Bristol Myers Squibb"},{"name":"ethinylestradiol","slug":"ethinylestradiol","company":"Schering"}],"globalPrevalence":null},{"indication":"Hypogonadotropic hypogonadism","otherDrugs":[{"name":"testosterone","slug":"testosterone","company":"Actient Pharms"},{"name":"testosterone undecanoate","slug":"testosterone-undecanoate","company":"Endo Pharms Inc"}],"globalPrevalence":null},{"indication":"Induction of final follicular maturation and luteinization","otherDrugs":[],"globalPrevalence":null},{"indication":"Induction of ovulation and pregnancy","otherDrugs":[],"globalPrevalence":null},{"indication":"Prepubertal cryptorchidism","otherDrugs":[],"globalPrevalence":null}],"mechanism":{"novelty":"First-in-class","modality":"Small Molecule","explanation":"","oneSentence":"","technicalDetail":"Choriogonadotropin is a glycoprotein hormone that binds to the luteinizing hormone receptor, triggering a cascade of intracellular signaling events that ultimately lead to the release of the egg from the ovary."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/5196","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=chorionic%20gonadotrophin","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=chorionic gonadotrophin","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T09:59:24.725077","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T03:28:29.741942+00:00","fieldsConflicting":2,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"follitropin","drugSlug":"follitropin","fdaApproval":"1986-09-18","relationship":"same-class"},{"drugName":"lutropin alfa","drugSlug":"lutropin-alfa","fdaApproval":"2004-10-08","relationship":"same-class"},{"drugName":"choriogonadotropin alfa","drugSlug":"choriogonadotropin-alfa","fdaApproval":"2000-09-20","relationship":"same-class"}],"genericName":"chorionic gonadotrophin","indications":{"approved":[{"name":"Controlled ovarian stimulation","source":"DrugCentral","snomedId":732970000,"regulator":"FDA"},{"name":"Hypogonadotropic hypogonadism","source":"DrugCentral","snomedId":33927004,"regulator":"FDA"},{"name":"Induction of final follicular maturation and luteinization","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Induction of ovulation and pregnancy","source":"DrugCentral","snomedId":61285001,"regulator":"FDA"},{"name":"Prepubertal cryptorchidism","source":"DrugCentral","snomedId":204878001,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"follitropin","brandName":"follitropin","genericName":"follitropin","approvalYear":"1986","relationship":"same-class"},{"drugId":"lutropin-alfa","brandName":"lutropin alfa","genericName":"lutropin alfa","approvalYear":"2004","relationship":"same-class"},{"drugId":"choriogonadotropin-alfa","brandName":"choriogonadotropin alfa","genericName":"choriogonadotropin alfa","approvalYear":"2000","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT05123040","phase":"PHASE1,PHASE2","title":"Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids","status":"TERMINATED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2023-06-05","conditions":["Acute-graft-versus-host Disease"],"enrollment":10,"completionDate":"2026-02-27"},{"nctId":"NCT04983173","phase":"PHASE4","title":"INTEnsity of ovariaN Stimulation and Embryo Quality","status":"RECRUITING","sponsor":"Fundación Santiago Dexeus Font","startDate":"2021-11-23","conditions":["Infertility"],"enrollment":110,"completionDate":"2026-06"},{"nctId":"NCT07358468","phase":"","title":"Impact Of FET Preparation Protocol On Endometrial Peristalsis: A Prospective Cohort Study","status":"RECRUITING","sponsor":"Mỹ Đức Hospital","startDate":"2026-02-22","conditions":["Infertility","Endometrial Peristalsis","Uterine Contraction","Endometrial Waves","Frozen Embryo Transfer (FET)","Uterine Peristalsis"],"enrollment":356,"completionDate":"2027-12-01"},{"nctId":"NCT07481370","phase":"PHASE2","title":"Isotretinoin vs hCG for Male Infertility Due to Low or Absent Sperm","status":"NOT_YET_RECRUITING","sponsor":"University of Nebraska","startDate":"2026-03-01","conditions":["Oligospermia","Azoospermia, Nonobstructive","Infertility"],"enrollment":100,"completionDate":"2026-12-31"},{"nctId":"NCT03785574","phase":"NA","title":"Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule","status":"RECRUITING","sponsor":"Women's Hospital School Of Medicine Zhejiang University","startDate":"2018-12-24","conditions":["Hydatidiform Mole","Gestational Trophoblastic Neoplasia"],"enrollment":30,"completionDate":"2030-09-01"},{"nctId":"NCT07450300","phase":"","title":"Assessment of the Feasibility of Frozen Embryo Transfers in a Natural Cycle Among Obese Compared to Non-Obese Patients","status":"COMPLETED","sponsor":"Clinique Mathilde","startDate":"2022-11-01","conditions":["Infertility, Female"],"enrollment":1831,"completionDate":"2026-01-31"},{"nctId":"NCT04886726","phase":"PHASE1","title":"PTCY Plus uhCG/EGF for Graft Versus Host Disease Prophylaxis","status":"RECRUITING","sponsor":"Henry Ford Health System","startDate":"2021-12-23","conditions":["Graft Versus Host Disease"],"enrollment":18,"completionDate":"2028-11-30"},{"nctId":"NCT06307184","phase":"","title":"Assessing the Convenience of Natural Proliferative Phase Frozen Embryo Transfer","status":"RECRUITING","sponsor":"Instituto Valenciano de Infertilidade de Lisboa","startDate":"2024-02-23","conditions":["Frozen Embryo Transfer"],"enrollment":530,"completionDate":"2026-12"},{"nctId":"NCT07425990","phase":"NA","title":"FET-LET-2x2: Clinical Pregnancy Rates After Frozen Embryo Transfer in Natural and Modified Natural Cycles","status":"NOT_YET_RECRUITING","sponsor":"University of Novi Sad","startDate":"2026-02","conditions":["Infertility Female","Frozen Embryo Transfer (FET)"],"enrollment":120,"completionDate":"2027-03"},{"nctId":"NCT06440850","phase":"PHASE2","title":"Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2024-07-15","conditions":["Thyroid Gland Follicular Carcinoma","Thyroid Gland Oncocytic Carcinoma","Thyroid Gland Papillary Carcinoma"],"enrollment":21,"completionDate":"2026-11-22"},{"nctId":"NCT06659692","phase":"PHASE1","title":"Pharmacokinetics of FSH and hCG Following Multiple Dose of Gonadotropins-IBSA.","status":"COMPLETED","sponsor":"IBSA Institut Biochimique SA","startDate":"2024-10-10","conditions":["Ovarian Stimulation","Infertility"],"enrollment":28,"completionDate":"2025-08-29"},{"nctId":"NCT06781957","phase":"PHASE1","title":"Pharmacokinetics of FSH and hCG After a Single Subcutaneous Injection of Gonadotropins-IBSA","status":"COMPLETED","sponsor":"IBSA Institut Biochimique SA","startDate":"2024-09-15","conditions":["OVARIAN STIMULATION","Infertility"],"enrollment":29,"completionDate":"2026-01-13"},{"nctId":"NCT07269392","phase":"PHASE4","title":"Dual Trigger With HCG and GnRH Agonist on Thawed Modified Natural Cycle Embryo Transfer","status":"NOT_YET_RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2026-01-01","conditions":["In Vitro Fertilization (IVF)","Embryo Transfer"],"enrollment":170,"completionDate":"2029-12-31"},{"nctId":"NCT05873725","phase":"","title":"Retrospective Study of High Dose Follitropin Delta in a Mixed Protocol With Human Chorionic Gonadotropin","status":"COMPLETED","sponsor":"Clinique Ovo","startDate":"2023-05-20","conditions":["IVF","Infertility"],"enrollment":118,"completionDate":"2024-03-19"},{"nctId":"NCT03428165","phase":"NA","title":"Transfer of Frozen Embryos in Natural Cycle: Evaluation of Impact of Spontaneous Versus HCG-triggered Ovulation on Pregnancy Rate","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2018-03-07","conditions":["in Vitro Fertilization"],"enrollment":103,"completionDate":"2022-02-01"},{"nctId":"NCT07028710","phase":"NA","title":"Early Luteal Phase Progesterone Kinetics After hCG-Induced Ovulation in Modified Natural Cycle","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Montpellier","startDate":"2026-01-15","conditions":["Luteal Phase Insufficiency"],"enrollment":40,"completionDate":"2030-06-15"},{"nctId":"NCT05343572","phase":"EARLY_PHASE1","title":"Bone Marrow Derived Stem Cells Mobilization for Treatment of Abnormal Endometrium","status":"RECRUITING","sponsor":"Hugh Taylor","startDate":"2023-11-01","conditions":["Asherman Syndrome","Atrophic Endometrium","Recurrent Implantation Failure"],"enrollment":90,"completionDate":"2027-12"},{"nctId":"NCT06877429","phase":"","title":"Is the Diurnal Variation in Circulating Levels of Cortisol Reflected in Follicular Fluid of Preovulatory Follicles Close to Ovulation?","status":"NOT_YET_RECRUITING","sponsor":"ART Fertility Clinics LLC","startDate":"2025-12-30","conditions":["Healthy"],"enrollment":20,"completionDate":"2026-12"},{"nctId":"NCT06879002","phase":"","title":"Comparing IVF/ICSI Cycle Outcomes of Post Ovulation Ovarian Stimulation Protocol With Elonva Without GnRH Antagonist to Follicular Phase Day 2 Stimulation Fixed Day 5 Antagonist Protocol","status":"NOT_YET_RECRUITING","sponsor":"ART Fertility Clinics LLC","startDate":"2025-12-30","conditions":["Stimulation in the Ovary","IVF Outcome"],"enrollment":252,"completionDate":"2026-12-30"},{"nctId":"NCT06372119","phase":"NA","title":"Letrozole-stimulated Cycle Strategy Versus Artificial Cycle Strategy (LETSACT)","status":"RECRUITING","sponsor":"Mỹ Đức Hospital","startDate":"2024-04-22","conditions":["Embryo Transfer","Irregular Menstruation","Letrozole","Hormone Replacement Therapy"],"enrollment":790,"completionDate":"2026-04"},{"nctId":"NCT06684951","phase":"PHASE4","title":"Effects of Intrauterine Flushing With Human Chorionic Gonadotropin on ICSI Outcome","status":"COMPLETED","sponsor":"Omayma Ismail Khalaf","startDate":"2022-10-23","conditions":["Female Infertility"],"enrollment":90,"completionDate":"2024-04-30"},{"nctId":"NCT06934785","phase":"NA","title":"LE + CC vs. LE for Ovulation Induction","status":"RECRUITING","sponsor":"Mỹ Đức Hospital","startDate":"2025-04-28","conditions":["Letrozole","Clomiphene Citrate","Ovulation Disorder","Ovulation Induction"],"enrollment":600,"completionDate":"2027-06-30"},{"nctId":"NCT06725004","phase":"PHASE3","title":"Oxytocin Versus Human Chorionic Gonadotropin as Trigger in Ovulation Induction","status":"COMPLETED","sponsor":"Shakeela Ishrat","startDate":"2023-01-01","conditions":["Ovulation Induction","Polycystic Ovary Syndrome"],"enrollment":60,"completionDate":"2024-06-30"},{"nctId":"NCT07128394","phase":"NA","title":"Extra Luteinizing Hormone Improve Embryo Quality in IVF Patients With Low LH During Long GnRH-Agonist Treatment","status":"RECRUITING","sponsor":"Nanjing University","startDate":"2024-02-01","conditions":["Infertility, Female","Luteinizing Hormone (LH)"],"enrollment":590,"completionDate":"2026-11-30"},{"nctId":"NCT06620835","phase":"PHASE2","title":"Trial for Local Ablative Treatment (LAT) Optimization in Patients With Advanced Non-Small Cells Lung Cancer (NSCLC) Presenting an Anaplastic Lymphoma Kinase (ALK) Rearrangement Treated by Brigatinib","status":"RECRUITING","sponsor":"Groupe Francais De Pneumo-Cancerologie","startDate":"2025-06-19","conditions":["NSCLC"],"enrollment":45,"completionDate":"2030-10-01"},{"nctId":"NCT06732843","phase":"","title":"Does Recombinant FSH (rFSH, i.g. Gonal F®) as Compared to Human Menopausal Gonadotrophin (hMG) Affect Telomere Length of Cumulus Cells During Antral Follicle Growth and Impact Blastocyst Status?","status":"RECRUITING","sponsor":"ART Fertility Clinics LLC","startDate":"2025-07-23","conditions":["OVARIAN STIMULATION","Telomere Length","Telomere Length, Mean Leukocyte"],"enrollment":10,"completionDate":"2027-07-31"},{"nctId":"NCT06875752","phase":"PHASE4","title":"Is There a Need for Luteal Support in Modified Natural Cycle Frozen Embryo Transfer Cycles","status":"RECRUITING","sponsor":"Dunamenti REK Istenhegyi IVF Center","startDate":"2025-04-12","conditions":["Luteal Support","Frozen Embryo Transfer (FET)"],"enrollment":180,"completionDate":"2026-12-01"},{"nctId":"NCT04551807","phase":"PHASE3","title":"Natural Versus Programmed Frozen Embryo Transfer (NatPro)","status":"ACTIVE_NOT_RECRUITING","sponsor":"JHSPH Center for Clinical Trials","startDate":"2020-09-16","conditions":["Pregnancy Related","Pre-Eclampsia"],"enrollment":788,"completionDate":"2026-04-01"},{"nctId":"NCT06906133","phase":"","title":"Sleep Quality and the Menstrual Cycle","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Akureyri","startDate":"2025-03-01","conditions":["Sleep Quality"],"enrollment":60,"completionDate":"2026-08-31"},{"nctId":"NCT06904599","phase":"PHASE2","title":"Efficacy of Human Chorionic Gonadotropin in Acute GVHD Treatment","status":"RECRUITING","sponsor":"Hospital Universitario Dr. Jose E. Gonzalez","startDate":"2025-02-01","conditions":["Acute Graft Versus Host Disease"],"enrollment":20,"completionDate":"2026-01-31"},{"nctId":"NCT06896617","phase":"PHASE4","title":"Impact of the Presence of the Corpus Luteum on Pregnancies Obtained Through Frozen Embryo Transfer(FET)","status":"RECRUITING","sponsor":"Fundacion Clinic per a la Recerca Biomédica","startDate":"2025-02-01","conditions":["Infertilities","Embryo Transfer"],"enrollment":334,"completionDate":"2026-12-20"},{"nctId":"NCT03737253","phase":"NA","title":"Hormone Evaluation in Artificial Reproductive Technology","status":"COMPLETED","sponsor":"Lund University","startDate":"2016-09","conditions":["Female Infertility"],"enrollment":810,"completionDate":"2024-10-02"},{"nctId":"NCT06754332","phase":"PHASE1","title":"The Study of Human Chorionic Gonadotropin (HCG) Activating the Dormant Follicles .","status":"NOT_YET_RECRUITING","sponsor":"The Fourth Affiliated Hospital of Zhejiang University School of Medicine","startDate":"2025-04-01","conditions":["Premature Ovarian Insufficiency"],"enrollment":60,"completionDate":"2029-08-31"},{"nctId":"NCT06792266","phase":"","title":"CircularRNA-microRNA-mRNA Regulatory Axis in IVF","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2025-03","conditions":["Infertility (IVF Patients)"],"enrollment":56,"completionDate":"2027-09-01"},{"nctId":"NCT02496754","phase":"NA","title":"Follicular Long GnRH Agonist Versus Antagonist Protocol in PCOS Women Undergoing in Vitro Fertilization","status":"COMPLETED","sponsor":"The First Affiliated Hospital of Zhengzhou University","startDate":"2016-06","conditions":["Clinical Pregnancy Rate","Ovulation Induction","IVF"],"enrollment":1266,"completionDate":"2024-12"},{"nctId":"NCT06280560","phase":"","title":"Impact of IVF Hormonal Therapy on Endometrial Receptivity and Endometrial Senescent Cell Pathological Accumulation","status":"RECRUITING","sponsor":"Fundación IVI","startDate":"2024-02-01","conditions":["Endometrial Receptivity"],"enrollment":60,"completionDate":"2025-12-30"},{"nctId":"NCT06572930","phase":"","title":"Serum FSH Monitoring for Identification of an Optimal Range During Ovarian Stimulation","status":"RECRUITING","sponsor":"ART Fertility Clinics LLC","startDate":"2024-12-16","conditions":["Ovarian Stimulation"],"enrollment":150,"completionDate":"2025-12-01"},{"nctId":"NCT06418347","phase":"PHASE3","title":"Effect of ALA Combined With Letrozole on Polycystic Ovary Syndrome Clinical Outcome in Infertile Females","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2024-04-01","conditions":["Polycystic Ovary Syndrome","Infertility, Female"],"enrollment":150,"completionDate":"2025-12-01"},{"nctId":"NCT05473273","phase":"","title":"Descriptive Analysis of Serum Immunological Markers During an Euploid Frozen Embryo Transfer in a Natural Cycle.","status":"RECRUITING","sponsor":"ART Fertility Clinics LLC","startDate":"2023-04-24","conditions":["Infertility, Female"],"enrollment":40,"completionDate":"2025-12-30"},{"nctId":"NCT04445025","phase":"EARLY_PHASE1","title":"Comparison Elagolix vs Depot Leuprolide Prior to Frozen Embryo Transfers in Patients With Endometriosis","status":"COMPLETED","sponsor":"Colorado Center for Reproductive Medicine","startDate":"2020-09-01","conditions":["Infertility","Endometriosis"],"enrollment":30,"completionDate":"2024-12-30"},{"nctId":"NCT06178523","phase":"PHASE4","title":"Cost-effective Treatment of Unexplained Infertility","status":"COMPLETED","sponsor":"Batterjee Medical College","startDate":"2024-01-01","conditions":["Unexplained Infertility"],"enrollment":900,"completionDate":"2024-12-31"},{"nctId":"NCT06599528","phase":"PHASE1","title":"A Comparing Study Between SJ04 and Ovidrel® in Healthy Subjects","status":"RECRUITING","sponsor":"Suzhou Centergene Pharmaceuticals Co.,Ltd.","startDate":"2024-08-12","conditions":["Assisted Reproductive Technology","Female Infertility"],"enrollment":48,"completionDate":"2026-12-31"},{"nctId":"NCT06074055","phase":"NA","title":"PRogrammed Versus Modified Natural Cycle After Euploid Failed Embryo Transfer","status":"TERMINATED","sponsor":"Reproductive Medicine Associates of New Jersey","startDate":"2023-10-25","conditions":["Infertility, Female"],"enrollment":9,"completionDate":"2024-10-21"},{"nctId":"NCT05330130","phase":"PHASE1","title":"Impact of FSH Dosage During Ovarian Stimulation for IVF/ICSI in Granulosa Cells","status":"COMPLETED","sponsor":"ART Fertility Clinics LLC","startDate":"2023-07-05","conditions":["Ovarian Function Insufficiency","Fertility Issues","Infertility,Female","Infertility"],"enrollment":6,"completionDate":"2024-06-30"},{"nctId":"NCT04997525","phase":"PHASE4","title":"Estradiol and Progesterone Levels Following Frozen Embryo Transfer","status":"COMPLETED","sponsor":"Copenhagen University Hospital at Herlev","startDate":"2021-04-20","conditions":["Infertility"],"enrollment":305,"completionDate":"2024-12-06"},{"nctId":"NCT03254641","phase":"","title":"Calciotropic Effects After HCG Stimulation Test","status":"COMPLETED","sponsor":"Martin Blomberg Jensen","startDate":"2017-04-01","conditions":["Hypogonadism, Male"],"enrollment":242,"completionDate":"2021-10-06"},{"nctId":"NCT06577181","phase":"","title":"Effect of HCG on Endometrial Preparation in Frozen Embryo Transfer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Assiut University","startDate":"2024-05-10","conditions":["IVF"],"enrollment":50,"completionDate":"2026-05-10"},{"nctId":"NCT00702338","phase":"","title":"Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05693 (P05713)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-05-15","conditions":["Pregnancy","Neonates"],"enrollment":1,"completionDate":"2008-12-15"},{"nctId":"NCT00702520","phase":"","title":"Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial 38833 (P05783)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-04-01","conditions":["Pregnancy","Neonates"],"enrollment":15,"completionDate":"2008-01-15"},{"nctId":"NCT00702234","phase":"","title":"Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05714 (Care Program)(P05715)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-02-15","conditions":["Pregnancy","Neonates"],"enrollment":268,"completionDate":"2010-01-15"},{"nctId":"NCT03115320","phase":"PHASE4","title":"Frozen-thawed Embryo Transfer in a Natural Cycle: hCG Triggering Versus LH Home Test","status":"TERMINATED","sponsor":"Tampere University Hospital","startDate":"2017-01","conditions":["Infertility"],"enrollment":62,"completionDate":"2019-12"},{"nctId":"NCT06561594","phase":"PHASE3","title":"To Evaluate Recombinant Human Follicle Stimulating Hormone-CTP Fusion Protein Injection or Placebo Combined With Chorionic Gonadotropin for Injection","status":"NOT_YET_RECRUITING","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2024-09-20","conditions":["Idiopathic Hypogonadotropic Hypogonadism"],"enrollment":60,"completionDate":"2026-12-23"},{"nctId":"NCT00702806","phase":"PHASE2","title":"Investigate Dose of Org 36286 to Initiate Multiple Follicular Growth in a Controlled Ovarian Hyperstimulation Protocol for IVF or IVF/ICSI (P07015)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2001-07-01","conditions":["Infertility","In Vitro Fertilization"],"enrollment":99,"completionDate":"2002-10-15"},{"nctId":"NCT02890082","phase":"PHASE2","title":"Preservation of Fertility by Ovarian Stimulation Associated With Tamoxifen, Prior Chemotherapy for Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Institut Cancerologie de l'Ouest","startDate":"2014-02","conditions":["Breast Cancer"],"enrollment":102,"completionDate":"2028-01"},{"nctId":"NCT04616417","phase":"NA","title":"Investigational Oocyte Cryopreservation for Medical and Non Medical Indications","status":"COMPLETED","sponsor":"University of Illinois at Chicago","startDate":"2015-05-08","conditions":["Infertility, Female","Deferred Childbearing"],"enrollment":29,"completionDate":"2023-03-20"},{"nctId":"NCT04804020","phase":"NA","title":"Natural Cycle vs. Modified Natural Cycle vs. Artificial Cycle Protocol for Endometrial Preparation.","status":"COMPLETED","sponsor":"Mỹ Đức Hospital","startDate":"2021-03-22","conditions":["IVF","Frozen Embryo Transfer"],"enrollment":1428,"completionDate":"2023-12-31"},{"nctId":"NCT06396390","phase":"PHASE4","title":"Comparison of Progestin Primed Ovarian Stimulation (PPOS) vs.GnRH Antagonist Methods on IVF Outcomes","status":"NOT_YET_RECRUITING","sponsor":"Nesta Clinic","startDate":"2024-08-01","conditions":["IVF","Fertility Issues","Infertility"],"enrollment":152,"completionDate":"2026-08-01"},{"nctId":"NCT06486870","phase":"PHASE3","title":"Comparison Between Two Ovulation Induction Therapies and LOD on Clinical Outcomes in CC-Resistant PCOS Women","status":"COMPLETED","sponsor":"Cairo University","startDate":"2020-01-01","conditions":["PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries"],"enrollment":183,"completionDate":"2024-01-31"},{"nctId":"NCT06486415","phase":"NA","title":"Novel Diagnosis of Ectopic Pregnancy","status":"NOT_YET_RECRUITING","sponsor":"Acibadem University","startDate":"2024-07-01","conditions":["Ectopic Pregnancy","hCG","Pregnancy of Unknown Location"],"enrollment":20,"completionDate":"2025-04-01"},{"nctId":"NCT00696800","phase":"PHASE3","title":"A Study to Investigate the Efficacy and Safety of a Single Injection of Corifollitropin Alfa (Organon 36286) for Ovarian Stimulation Using Daily Recombinant Follicle Stimulating Hormone (FSH) as Reference (P05787)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-06-27","conditions":["In Vitro Fertilization"],"enrollment":1509,"completionDate":"2008-01-15"},{"nctId":"NCT00702845","phase":"PHASE3","title":"To Investigate Efficacy and Safety of a Single Injection of Org 36286 for Ovarian Stimulation Using Daily Recombinant FSH as Reference (Ensure)(P05690/MK-8962-001)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-12-28","conditions":["Infertility"],"enrollment":397,"completionDate":"2007-11-15"},{"nctId":"NCT00696878","phase":"PHASE3","title":"Corifollitropin Alfa in Participants Undergoing Repeated Controlled Ovarian Stimulation (COS) Cycles Using a Multiple Dose Gonadatropin Releasing Hormone (GnRH) Antagonist Protocol (Study 38825)(P05714)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-09-26","conditions":["In Vitro Fertilization"],"enrollment":682,"completionDate":"2009-05-15"},{"nctId":"NCT00697255","phase":"PHASE2","title":"A Phase 2 Trial to Evaluate if Corifollitropin Alfa (Org 36286), Followed by a Low Daily Dose of hCG or Recombinant FSH Can Induce Monofollicular Growth in Women With WHO Group II Anovulatory Infertility (P05693)","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2007-05-15","conditions":["Ovulation Induction"],"enrollment":8,"completionDate":"2008-05-15"},{"nctId":"NCT05828966","phase":"NA","title":"HUMAN CHORIONIC GONADOTROPIN (HcG) VS MAGNESIUM SULPHATE (MgSo4) AS A TOCOLYTIC AGENT- A RANDOMIZED CONTROLLED TRIAL","status":"COMPLETED","sponsor":"Shaheed Zulfiqar Ali Bhutto Medical University","startDate":"2023-02-15","conditions":["Preterm Labor"],"enrollment":70,"completionDate":"2023-12-20"},{"nctId":"NCT01709331","phase":"PHASE3","title":"A Study of the Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adult Men With Hypogonadotropic Hypogonadism (HH) (P07937)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2013-02-11","conditions":["Hypogonadism","Hypogonadotropic Hypogonadism"],"enrollment":18,"completionDate":"2015-04-08"},{"nctId":"NCT03019575","phase":"PHASE3","title":"Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adolescent Males With Hypogonadotropic Hypogonadism (HH) (MK-8962-043)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2017-02-02","conditions":["Hypogonadotropic Hypogonadism"],"enrollment":17,"completionDate":"2020-05-05"},{"nctId":"NCT04719000","phase":"PHASE4","title":"PErsonalized Addition of Recombinant LH in Ovarian Stimulation","status":"RECRUITING","sponsor":"Fundación Santiago Dexeus Font","startDate":"2021-02-04","conditions":["Infertility"],"enrollment":120,"completionDate":"2025-11"},{"nctId":"NCT03846544","phase":"PHASE4","title":"Double Pick up in Poor Prognosis Women","status":"COMPLETED","sponsor":"CRG UZ Brussel","startDate":"2019-10-01","conditions":["Fertility Disorders"],"enrollment":48,"completionDate":"2022-10-01"},{"nctId":"NCT06410417","phase":"NA","title":"Ejaculation Abstinence Time and Assisted Reproductive Technology Outcomes","status":"RECRUITING","sponsor":"The First Hospital of Jilin University","startDate":"2024-05-01","conditions":["Fertilization in Vitro"],"enrollment":500,"completionDate":"2025-08-01"},{"nctId":"NCT04820985","phase":"","title":"Analysis of the Composition of the Vaginal Microbiota During IVF Treatment and Correlation With Serum Progesterone Level on the Day of Embryo Transfer","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2021-05-26","conditions":["IVF"],"enrollment":60,"completionDate":"2024-04-22"},{"nctId":"NCT06356740","phase":"PHASE2","title":"Efficacy and Tolerance of Abacavir/Lamivudine Treatment in Patients With Systemic Lupus Erythematosus","status":"NOT_YET_RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2024-09-01","conditions":["Systemic Lupus Erythematosus"],"enrollment":70,"completionDate":"2029-06-01"},{"nctId":"NCT04092829","phase":"NA","title":"Impact of Corpus Luteum Presence or Absence in the Incidence of Preeclampsia After Frozen Embryo Transfer","status":"TERMINATED","sponsor":"Instituto Valenciano de Infertilidad, IVI VALENCIA","startDate":"2019-09-16","conditions":["Pre-Eclampsia","Frozen Embryo Transfer"],"enrollment":591,"completionDate":"2022-12-31"},{"nctId":"NCT04989348","phase":"NA","title":"Euploid Rate of Blastocyst Derived From PPOS VS Antagonist Protocol","status":"COMPLETED","sponsor":"Shanghai First Maternity and Infant Hospital","startDate":"2021-08-04","conditions":["IVF"],"enrollment":240,"completionDate":"2024-02-20"},{"nctId":"NCT05670795","phase":"NA","title":"Comparison of Recombinant Follicle Stimulating Hormone and the Combination of Recombinant Follicle Stimulating Hormone With Clomiphene Citrate in Stimulated Intrauterine Insemination Cycles","status":"UNKNOWN","sponsor":"Bezmialem Vakif University","startDate":"2023-01-01","conditions":["Infertility Unexplained"],"enrollment":254,"completionDate":"2024-05-01"},{"nctId":"NCT06228118","phase":"","title":"Clinical Trail of the Lay User Study and Method Comparison Study of Human Chorionic Gonadotropin (HCG) Test System","status":"COMPLETED","sponsor":"Andon Health Co., Ltd","startDate":"2023-08-04","conditions":["Early Pregnancy"],"enrollment":502,"completionDate":"2023-09-02"},{"nctId":"NCT05586802","phase":"PHASE3","title":"Sex Steroids Balance for Metabolic and Reproductive Health in Klinefelter Syndrome","status":"RECRUITING","sponsor":"Georgios Papadakis","startDate":"2023-03-21","conditions":["Klinefelter Syndrome"],"enrollment":150,"completionDate":"2026-04-01"},{"nctId":"NCT04855383","phase":"NA","title":"Intramuscular Injection of Human Chorionic Gonadotropin in Frozen Embryo Transfer Cycles","status":"COMPLETED","sponsor":"Royan Institute","startDate":"2020-07-01","conditions":["Embryo Implantation"],"enrollment":200,"completionDate":"2023-06-20"},{"nctId":"NCT02525029","phase":"PHASE1,PHASE2","title":"Study of Pregnyl as Adjunct Therapy for High-Risk or Refractory Acute GVHD","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2016-03","conditions":["Graft vs Host Disease"],"enrollment":53,"completionDate":"2022-04"},{"nctId":"NCT05567731","phase":"NA","title":"Effect of GnRH Agonist Treatment Protocols on Ovarian Reserve","status":"COMPLETED","sponsor":"Tanta University","startDate":"2022-10-15","conditions":["Intracytoplasmic Sperm Injection","GnRH Agonist","Infertility","Ovarian Reserve"],"enrollment":30,"completionDate":"2023-12-01"},{"nctId":"NCT06142708","phase":"NA","title":"The Effect of Dual Trigger (GnRH Agonist + hCG) for Final Maturation in Oocyte Donors With History of a Previous Cycle With Suboptimal Response to GnRH Agonist Only Trigger","status":"UNKNOWN","sponsor":"Embryolab Fertility Clinic","startDate":"2023-11-01","conditions":["Ovarian Stimulation","Human Chorionic Gonadotropin","Oocyte Donors"],"enrollment":80,"completionDate":"2026-02"},{"nctId":"NCT03905603","phase":"EARLY_PHASE1","title":"Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS","status":"RECRUITING","sponsor":"University of Virginia","startDate":"2019-10-08","conditions":["Polycystic Ovary Syndrome"],"enrollment":144,"completionDate":"2026-05-01"},{"nctId":"NCT02436226","phase":"PHASE4","title":"Use of Low Dose of HCG During Ovulation Induction With CC in Women With CC Resistant PCOS","status":"COMPLETED","sponsor":"Mohamed Sayed Abdelhafez","startDate":"2016-03","conditions":["Infertility","Polycystic Ovarian Syndrome"],"enrollment":300,"completionDate":"2023-01"},{"nctId":"NCT02330770","phase":"PHASE4","title":"Dual Trigger Versus GnRHa Trigger Combined With Luteal HCG Administration","status":"UNKNOWN","sponsor":"Mansoura University","startDate":"2016-06-06","conditions":["Infertility"],"enrollment":225,"completionDate":"2024-12-31"},{"nctId":"NCT02330757","phase":"PHASE4","title":"HRT Versus MOS for Endometrial Preparation Prior to FET in Non PCOS Patients","status":"UNKNOWN","sponsor":"Mansoura University","startDate":"2016-10-10","conditions":["Infertility"],"enrollment":150,"completionDate":"2024-12-31"},{"nctId":"NCT01421810","phase":"NA","title":"Ovarian Contribution to Androgen Production in Adolescent Girls","status":"UNKNOWN","sponsor":"University of Virginia","startDate":"2011-03-10","conditions":["Polycystic Ovary Syndrome","Obesity","Hyperandrogenism"],"enrollment":80,"completionDate":"2025-12"},{"nctId":"NCT04724486","phase":"PHASE4","title":"Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology During IVF/ICSI","status":"COMPLETED","sponsor":"Damascus University","startDate":"2020-08-22","conditions":["In Vitro Fertilization","Intracytoplasmic Sperm Injection","Infertility"],"enrollment":50,"completionDate":"2022-07-15"},{"nctId":"NCT04724343","phase":"PHASE4","title":"Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes.","status":"COMPLETED","sponsor":"Damascus University","startDate":"2019-12-22","conditions":["In Vitro Fertilization","Intracytoplasmic Sperm Injection","Infertility"],"enrollment":50,"completionDate":"2022-07-05"},{"nctId":"NCT04727684","phase":"PHASE4","title":"Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology in Polycystic Ovary Syndrome Patients During IVF/ICSI","status":"COMPLETED","sponsor":"Damascus University","startDate":"2020-08-22","conditions":["In Vitro Fertilization","Infertility","Intracytoplasmic Sperm Injection","Polycystic Ovary Syndrome"],"enrollment":50,"completionDate":"2022-05-12"},{"nctId":"NCT04727671","phase":"PHASE4","title":"Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients.","status":"COMPLETED","sponsor":"Damascus University","startDate":"2019-12-22","conditions":["In Vitro Fertilization","Intracytoplasmic Sperm Injection","Infertility","Polycystic Ovary Syndrome"],"enrollment":50,"completionDate":"2021-12-30"},{"nctId":"NCT05483621","phase":"PHASE1","title":"Hormonal Stimulation of Spermatogenesis","status":"COMPLETED","sponsor":"Egymedicalpedia","startDate":"2021-03-01","conditions":["Azoospermia, Nonobstructive"],"enrollment":100,"completionDate":"2022-03-01"},{"nctId":"NCT04447872","phase":"NA","title":"The LUTEAL Trial: Luteal Stimulation vs. Estrogen Priming Protocol","status":"UNKNOWN","sponsor":"Northwell Health","startDate":"2020-09-15","conditions":["Infertility","Diminished Ovarian Reserve","IVF"],"enrollment":142,"completionDate":"2025-06"},{"nctId":"NCT06026553","phase":"PHASE1","title":"Assessing Ketorolac (Toradol) at Oocyte Retrieval","status":"UNKNOWN","sponsor":"Shady Grove Fertility Reproductive Science Center","startDate":"2022-08-10","conditions":["Infertility","Infertility, Female","Oocyte Retrieval","Postoperative Pain","Embryo Transfer"],"enrollment":400,"completionDate":"2025-01"},{"nctId":"NCT03495609","phase":"PHASE4","title":"Use of Recombinant hCG to Prevent Breast Cancer in BRCA1 and BRCA2 Carriers","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2016-02-17","conditions":["hCG","BRCA1 Mutation","BRCA2 Mutation"],"enrollment":33,"completionDate":"2018-12-18"},{"nctId":"NCT03564509","phase":"PHASE2","title":"A Trial to Investigate the Efficacy and Safety of FE 999302 as add-on Treatment to Follitropin Delta (REKOVELLE) in Women Undergoing Controlled Ovarian Stimulation.","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2018-05-14","conditions":["Controlled Ovarian Stimulation"],"enrollment":620,"completionDate":"2020-01-08"},{"nctId":"NCT05969834","phase":"","title":"HCG Levels After Ovulation Triggering as Predictors of ICSI Outcome","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2021-03-31","conditions":["Infertility"],"enrollment":100,"completionDate":"2022-08-07"},{"nctId":"NCT04992468","phase":"PHASE4","title":"Dual Trigger for Elective Fertility Preservation","status":"COMPLETED","sponsor":"Fundación Santiago Dexeus Font","startDate":"2021-10-05","conditions":["Infertility"],"enrollment":136,"completionDate":"2023-04-25"},{"nctId":"NCT04189133","phase":"PHASE2","title":"Rec-LH PD and Safety Profile in Hypogonadotropic Hypogonadism Men","status":"UNKNOWN","sponsor":"Azienda Ospedaliero-Universitaria di Modena","startDate":"2022-01-19","conditions":["Acquired Hypogonadotropic Hypogonadism"],"enrollment":32,"completionDate":"2026-01-18"},{"nctId":"NCT05638529","phase":"PHASE4","title":"Dual Trigger\" in IVF Patients at High Risk of Ovarian Hyper Stimulation Syndrome","status":"UNKNOWN","sponsor":"Mount Sinai Hospital, Canada","startDate":"2019-05-01","conditions":["Ovarian Hyperstimulation Syndrome","Infertility, Female"],"enrollment":80,"completionDate":"2023-12-31"},{"nctId":"NCT04549649","phase":"NA","title":"The Effect of Dual Trigger for Final Oocyte Maturation on IVF/ICSI Outcomes in Patients With Suboptimal Ovarian Response","status":"COMPLETED","sponsor":"Royan Institute","startDate":"2019-11-01","conditions":["Ovarian Stimulation","Reproductive Techniques, Assisted"],"enrollment":52,"completionDate":"2022-11-30"},{"nctId":"NCT03418896","phase":"PHASE1","title":"Extragonadal Effects of hCG on Calcium Homeostasis","status":"COMPLETED","sponsor":"Martin Blomberg Jensen","startDate":"2018-01-06","conditions":["Hypogonadism","Calcium Disorder","Renal Disease"],"enrollment":12,"completionDate":"2022-12-31"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"MMSL":"4330","NDDF":"001254","UNII":"20ED16GHEB","VANDF":"4017617","INN_ID":"1972","RXNORM":"340705","UMLSCUI":"C0018062","chemblId":"CHEMBL1201509","ChEMBL_ID":"CHEMBL1201509","KEGG_DRUG":"D06457","DRUGBANK_ID":"DB09126","SNOMEDCT_US":"20577002","SECONDARY_CAS_RN":"177073-44-8","MESH_DESCRIPTOR_UI":"D006063"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[{"period":"","companyName":"Ferring","relationship":"Original Developer"}],"publicationCount":5105,"therapeuticAreas":["Metabolic"],"atcClassification":{"source":"DrugCentral","atcCode":"G03GA01","allCodes":["G03GA01"]},"biosimilarFilings":[],"originalDeveloper":"Ferring","recentPublications":[{"date":"2026 Mar 22","pmid":"41887127","title":"Activity-based costing in the management of pregnancy of unknown Location: Comparing current practice in Denmark with the M6NP model, and the NICE guidelines.","journal":"European journal of obstetrics, gynecology, and reproductive biology"},{"date":"2026 Mar 25","pmid":"41866201","title":"[Risk assessment of subsequent drug resistance in patients with chemoresistant gestational trophoblastic neoplasia].","journal":"Zhonghua fu chan ke za zhi"},{"date":"2025 Dec 25","pmid":"41826105","title":"AI-driven paradigm shift in follicle ultrasound monitoring: from automated segmentation to clinical decision support.","journal":"Reproductive biomedicine online"},{"date":"2026 Feb 20","pmid":"41720851","title":"LK-1: an investigational therapy targeting hCG-β in metastatic breast, bladder, ovarian, and cervical cancers.","journal":"Scientific reports"},{"date":"2026 Mar","pmid":"41637911","title":"Risk of progesterone elevation in patients with low ovarian reserve using long-acting FSH IVF protocol: a randomized controlled trial.","journal":"Reproductive biomedicine online"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"Ferring","companyId":"ferring","modality":"Small Molecule","firstApprovalDate":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"FERRING","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"BR","regulator":"ANVISA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MX","regulator":"COFEPRIS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AR","regulator":"ANMAT","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TR","regulator":"TITCK","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IN","regulator":"CDSCO","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TH","regulator":"FDA-TH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MY","regulator":"NPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"PH","regulator":"FDA-PH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"CO","regulator":"INVIMA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"ZA","regulator":"SAHPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TW","regulator":"TFDA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"HK","regulator":"DH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T03:28:29.741942+00:00","fieldsConflicting":2,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}